Yvette Dapremont Bright
About Yvette Dapremont Bright
Yvette Dapremont Bright (age 63) is an independent director of Myers Industries (MYE) since 2021. She is President of the Brighter Horizon Foundation and formerly served as EVP & COO (also Chief Transformation Officer and Chief Administrative Officer) of Independence Blue Cross, bringing deep operating, transformation, and shared-services experience; she currently serves on MYE’s Audit and Corporate Governance Committees .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Independence Blue Cross | EVP & COO; Chief Transformation Officer; Chief Administrative Officer | — | Led enterprise operating platform and cultural transformation; oversight of operations/shared services and business technology services |
External Roles
| Organization | Role | Status | Notes |
|---|---|---|---|
| Independence Blue Cross | Director | Current | — |
| Cityblock Health | Director | Current | Private health services/tech company |
| National Life Group | Director | Current | Mutual life insurer; note interlock with MYE director Bruce M. Lisman who is also a director |
| Clarify Health Solutions | Advisory Director | Current | Healthcare software (advisory role) |
| CSAA Insurance Group (AAA) | Director | Current | P&C insurer for AAA members |
| Reveleer | Director | Former | Health plan/provider software platform |
| Independence Health Group | Director | Former | Diversified healthcare company (parent of Independence Blue Cross) |
| AmeriHealth Insurance Co. of New Jersey | Director and Chair | Former | — |
| AmeriHealth Caritas | Director | Former | Medicaid managed care organization |
Board Governance
- Independence and roles:
- Independent director; Board is 100% independent other than the CEO .
- Committees: Audit and Corporate Governance; not a chair .
- Meetings and attendance:
- 2024 Board meetings: 6; committee meetings total: 17; Board held formal education (including AI training by outside experts) .
- All directors attended at least 75% of aggregate Board/committee meetings; all directors/nominees attended the 2024 Annual Meeting .
- Committee cadence: Audit (5 meetings in 2024); Governance (4 meetings in 2024) .
- Structure and practices:
- Independent Board Chair (independent chair since 2009; current chair since 2016) .
- Executive sessions held regularly at each Board and committee meeting (independent directors only) .
- Anti-hedging and anti-pledging policy; proxy access; over-boarding policy (non-CEO directors ≤5 public boards) .
- Stock ownership guidelines: Non-employee directors must hold 5x annual cash Board retainer within five years .
- Say-on-pay support: 99% approval at 2024 meeting (positive alignment signal) .
- Shareholder outreach: contacted top 25 holders (>75% of shares) and engaged with eight in 2024 .
Fixed Compensation
| Component | Amount/Detail | Source |
|---|---|---|
| Annual cash retainer (non-employee directors) | $100,000 | |
| Annual equity award (target value) | $100,000 (RSUs; granted for upcoming year, vests at next Annual Meeting) | |
| Committee chair fees | Audit Chair $17,500; CMD Chair $12,500; Governance Chair $10,000 | |
| Board Chair supplemental retainer | $90,000 | |
| Bright – 2024 reported fees | $100,000 cash | |
| Bright – 2024 reported stock award (grant-date FMV) | $77,939 (4,534 RSUs granted 5/9/2024) | |
| Bright – 2024 total director comp | $177,939 | |
| Settlement/deferral feature | Directors may elect stock units instead of shares; paid after Board service ends |
Performance Compensation
- Not applicable for non-employee directors: MYE’s director equity grants are service-based RSUs (no performance metrics). Annual grant vests at the following Annual Meeting; no annual or long-term performance metrics apply to director pay .
Other Directorships & Interlocks
| Company | Type | Interlock/Notes |
|---|---|---|
| National Life Group | Mutual life insurer | Shared directorship with MYE director Bruce M. Lisman (board-level network interlock; different industry from MYE) |
| Related-party transactions at MYE | — | None occurred in fiscal 2024 (reduces conflict risk) |
Expertise & Qualifications
- Senior management expertise leading large-scale operations, customer service, shared services, business process re-engineering, and business technology; enterprise-wide transformation leadership; HR, strategy, innovation, operational planning, and portfolio management for strategic initiatives .
- Governance contribution via Audit and Governance Committee service; Audit Committee financial expert designations are held by Foley, Liebau, and Lutey (Bright is not the designated “financial expert”) .
Equity Ownership
| Holder | Beneficially Owned Shares | % of Shares Outstanding | Notes |
|---|---|---|---|
| Yvette Dapremont Bright | 20,961 | 0.06% (calc.) | Based on 37,295,964 shares outstanding as of 3/6/2025; calculation: 20,961 ÷ 37,295,964 ≈ 0.06% |
| Policy considerations | — | — | Anti-hedging and anti-pledging policy in effect; director stock ownership guideline = 5x annual cash retainer; 5-year compliance window |
| Director equity structure | — | — | Directors can elect to defer equity into stock units, payable after Board service |
Governance Assessment
- Positives
- Independent director with dual committee service (Audit and Governance) and relevant operating/transformation background; Board maintained 100% independence among non-management directors .
- Strong alignment features: mandatory director ownership guidelines, anti-hedging/pledging policy, and equity-based director pay with deferral option .
- No related-party transactions in 2024; robust shareholder outreach; executive sessions each meeting; independent Chair structure .
- Board education (AI, cybersecurity) and strong say-on-pay support (99%) bolster investor confidence in oversight and compensation governance .
- Watch items
- Network interlock: Shared National Life Group directorship with fellow MYE director Bruce M. Lisman; not a direct conflict given different industries but noteworthy for information flow dynamics .
- Attendance disclosure is aggregate (≥75% for all directors) rather than individual; no red flag disclosed, but limited individual transparency .
- Audit Committee “financial expert” designation sits with other members (not Bright), which may shape her committee influence on technical accounting matters .
Additional board-level signal: Six directors purchased MYE stock in the open market following CEO Aaron Schapper’s appointment, indicating confidence in leadership transition (names not specified) .